LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: a novel approach to personalized medicine
S Fattahi, M Kosari‐Monfared… - Journal of cellular …, 2020 - Wiley Online Library
Gastric cancer is the third leading cause of cancer death with 5‐year survival rate of about
30–35%. Since early detection is associated with decreased mortality, identification of novel …
30–35%. Since early detection is associated with decreased mortality, identification of novel …
LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
S Fattahi, M Kosari-Monfared, M Golpour… - Journal of Cellular …, 2019 - europepmc.org
Gastric cancer is the third leading cause of cancer death with 5-year survival rate of about 30-
35%. Since early detection is associated with decreased mortality, identification of novel …
35%. Since early detection is associated with decreased mortality, identification of novel …
LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine
S Fattahi, M Kosari-Monfared… - Journal of cellular …, 2020 - pubmed.ncbi.nlm.nih.gov
Gastric cancer is the third leading cause of cancer death with 5-year survival rate of about 30-
35%. Since early detection is associated with decreased mortality, identification of novel …
35%. Since early detection is associated with decreased mortality, identification of novel …